DL-5016

N/A

Report date: 2024/11/21 15:14:14
NME

Base Information

Drug NameDL-5016
Drug Alias NameDL-5016DL-5055
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor subfamily 1 group I member 3 agonists
TargetsNuclear receptor subfamily 1 group I member 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Maryland, Baltimore
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Maryland, Baltimore
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A